参考文献/References:
［1］HUANG J, LOK V, NGAI C H, et al.Worldwide burden of, risk factors for, and trends in pancreatic cancer [J ]. Gastroenterology ,2021, 160:744 -754. [2 ]BOARD P D Q A T E.Pancreatic cancer treatment (Adult) (PDQ): patient version [C ]. In PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US),2002. [3 ]EDGAR R, DOMRACHEV M, LASH A E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository [J ]. Nucleic Acids Res, 2002, 30:207 -210. [4 ]FRAMPTON A E, L CASTELLANO, T COLOMBO, et al.MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression [J ]. Gastroenterology ,2014, 146:268 -277. [5 ]SUTARIA D S, JIANG J, AZEVEDO -POULY A C P, et al. Expression profiling identifies the noncoding processed transcript of hnrnpu with proliferative properties in pancreatic ductal adenocarcinoma [J ]. Noncoding RNA ,2017, 3(03), 24. [6 ]PARK M, KIM M, HWANG D, et al. Characterization of gene expression and activated signaling pathways in solid -pseudopapillary neoplasm of pancreas [J ]. Mod Pathol ,2014, 27:580 -593. [7 ]DAVIS S, MELTZER P S.Geoquery: a bridge between the gene expression omnibus (GEO) and bioconductor [J ]. Bioinformatics, 2007, 23:1846 -1847. [8 ]KANEHISA M, Goto S. KEGG: kyoto encyclopedia of genes and genomes [J ]. Nucleic Acids Res ,2000, 28:27 -30. [9 ]ASHBURNER M, BALL C A, BLAKE J A, et al. Gene ontology: tool for the unification of biology. the gene ontology consortium [J ]. Nat Genet ,2000, 25:25 -29. [10 ] HUANG DA W, SHERMAN B T, LEMPICKI R A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources [J ]. Nat Protoc, 2009, 4:44 -57. [11 ] SZKLARCZYK D, GABLE A L, LYOD N, ET al. STRING v11: protein -protein association networks with increased coverage, supporting functional discovery in genome -wide experimental datasets [J ]. Nucleic Acids Res ,2019, 47:D607 -D613. [12 ] SHANNON P, MARKIE A L, OZIER O, et al: Cytoscape: a software environment for integrated models of biomolecular interaction networks [J ]. Genome Res ,2003, 13:2498 -2504. [13 ] BADER G D, HOGUE C W. An automated method for finding molecular complexes in large protein interaction networks [J ]. BMC Bioinformatics ,2003, 4:2. [14 ] MAERE S, HEYMANS K, KUIPER M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks [J ]. Bioinformatics,2005, 21:3448 -3449. [15 ] STELZER G, ROSEN N, PLASCHKES I, et al: The genecards suite: from gene data mining to disease genome sequence analyses [J ]. Curr Protoc Bioinformatics, 2016, 54:1.30.31 -31.30.33. [16 ] TANG Z, KANG B, LI C, et al. GEPIA2: an enhanced web server for large -scale expression profiling and interactive analysis [J ]. Nucleic Acids Res,2019, 47:556 -560. [17 ] GYRFFY B.Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer [J ]. Comput Struct Biotechnol J ,2021, 19:4101 -4109. [18 ] NAGY, MUNKCSY, GYRFFY G B. Pancancer survival analysis of cancer hallmark genes [J ]. Sci Rep,2021, 11:6047. [19 ] PEI H, LI L, B FRIDLEY L, et al: FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt [J ]. Cancer Cell ,2009, 16:259 -266. [20 ] SEGARA D, BIANKIN A V, KENCH J G, et al. Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia [J ]. Clin Cancer Res, 2005, 11:3587 -3596. [21 ] JIANG H, HEGDE S, DeNardo D G. Tumor -associated fibrosis as a regulator of tumor immunity and response to immunotherapy [J ]. Cancer Immunol Immunother, 2017, 66:1037 -1048. [22 ] APTE M V, PARK S, PHILLIPS P A, et al: Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells [J ]. Pancreas,2004, 29:179 -187. [23 ] ABE T, M UNNO, T ONOGAWA, et al: LST -2, a human liver -specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers [J ]. Gastroenterology,2001, 120:1689 -1699. [24 ] DURLIK M, GARDIAN K. Metalloproteinase 2 and 9 activity in the development of pancreatic cancer [J ]. Pol Przegl Chir,2012, 84:377 -382. [25 ] CORTESE N, CAPRETTI G, BARBAGALLO M, et al. Metabolome of pancreatic juice delineates distinct clinical profiles of pancreatic cancer and reveals a link between glucose metabolism and PD -1(+) Cells [J ]. Cancer Immunol Res ,2020, 8:493 -505. [26 ] KASLOFF S B, PIZZUTO M S, SILIC -BENUSSI M, et al. Oncolytic activity of avian influenza virus in human pancreatic ductal adenocarcinoma cell lines [J ]. J Virol ,2014, 88:9321 -9334. [27 ] CALORE E E, UIP D E, PEREZ N M. Pathology of the swine -origin influenza A (H1N1) flu [J ]. Pathol Res Pract, 2011, 207:86 -90. [28 ] HUO C, XIAO K, ZHANG S, et al. H5N1 Influenza a Virus Replicates Productively in Pancreatic Cells and Induces Apoptosis and Pro -Inflammatory Cytokine Response [J ]. Front Cell Infect Microbiol,2018, 8:386. [29 ] XIN D, LIU J, GU J, et al. Low Expression of DDX60 Gene Might Associate with the Radiosensitivity for Patients with Breast Cancer [J ]. Hindawi Journal of Oncol ,2020:8309492. [30 ] MIYASHITA M, OSHIUMI H, MATSUMOTO M, et al: DDX60, a DEXD/H box helicase, is a novel antiviral factor promoting RIG -I -like receptor -mediated signaling [J ]. Mol Cell Biol ,2011, 31:3802 -3819. [31 ] GRNVOGEL O, ESSER -NOBIS K, REUSTLE A, et al: DDX60L Is an Interferon -Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture [J ]. J Virol ,2015, 89:10548 -10568. [32 ] MOHAMMED A, N B JANAKIRAM, SUEN C, et al: Targeting cholecystokinin -2 receptor for pancreatic cancer chemoprevention [J ]. Mol Carcinog,2019, 58:1908 -1918. [33 ] SCHUTYSER E, STRUYF S, VAN DAMME J. The CC chemokine CCL20 and its receptor CCR6 [J ]. Cytokine Growth Factor Rev ,2003, 14:409 -426. [34 ] RUBIE C, V O FRICK, GHADJAR P, et al: CCL20/CCR6 expression profile in pancreatic cancer [J ]. J Transl Med ,2010, 8:45. [35 ] KIMSEY T F, CAMPBELL A S, ALBO D, et al.Co -localization of macrophage inflammatory protein -3alpha (Mip -3alpha) and its receptor, CCR6, promotes pancreatic cancer cell invasion [J ]. Cancer J 2004, 10:374 -380. [36 ] KLEEFF J, KUSAMA T, ROSSI D L, et al. Detection and localization of Mip -3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer [J ]. Int J Cancer ,1999, 81:650 -657. [37 ] WU H H, HWANG -VERSLUES W W, LEE W H, et al. Targeting IL -17B -IL -17RB signaling with an anti -IL -17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines [J ]. J Exp Med ,2015, 212:333 -349. [38 ] CAMPBELL A S, ALBO D, KIMSEY T F, et al. Macrophage inflammatory protein -3alpha promotes pancreatic cancer cell invasion [J ]. J Surg Res ,2005, 123:96 -101.